Immunome (IMNM) EPS (Weighted Average and Diluted) (2023 - 2025)
Historic EPS (Weighted Average and Diluted) for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to -$0.65.
- Immunome's EPS (Weighted Average and Diluted) rose 1666.67% to -$0.65 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.95, marking a year-over-year increase of 6362.52%. This contributed to the annual value of -$5.21 for FY2024, which is 306.84% up from last year.
- Latest data reveals that Immunome reported EPS (Weighted Average and Diluted) of -$0.65 as of Q3 2025, which was up 1666.67% from -$0.5 recorded in Q2 2025.
- In the past 5 years, Immunome's EPS (Weighted Average and Diluted) registered a high of -$0.35 during Q1 2023, and its lowest value of -$4.22 during Q4 2023.
- Over the past 3 years, Immunome's median EPS (Weighted Average and Diluted) value was -$0.6 (recorded in 2024), while the average stood at -$1.12.
- Per our database at Business Quant, Immunome's EPS (Weighted Average and Diluted) tumbled by 61714.29% in 2024 and then surged by 7928.29% in 2025.
- Over the past 3 years, Immunome's EPS (Weighted Average and Diluted) (Quarter) stood at -$4.22 in 2023, then skyrocketed by 66.47% to -$1.41 in 2024, then skyrocketed by 54.06% to -$0.65 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.65 in Q3 2025, compared to -$0.5 in Q2 2025 and -$0.52 in Q1 2025.